Krystal Biotech Inc
NASDAQ:KRYS

Watchlist Manager
Krystal Biotech Inc Logo
Krystal Biotech Inc
NASDAQ:KRYS
Watchlist
Price: 163.78 USD 0.36% Market Closed
Updated: May 17, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

818.4m
+4%
Assets
Growth Rates:
1 Year
+47%
3 Years
+163%
5 Years
+605%
7 Years
+37 098%
10 Years
-
39.7m
+15%
Liabilities
Growth Rates:
1 Year
+10%
3 Years
+111%
5 Years
+1 269%
7 Years
+1 990%
10 Years
-
778.6m
+3%
Equity
Growth Rates:
1 Year
+49%
3 Years
+167%
5 Years
+588%
7 Years
+259 447%
10 Years
-

Balance Sheet Decomposition
Krystal Biotech Inc

818.4m
Assets
39.7m
Liabilities
818.4m
Assets
39.7m
Liabilities
Current Assets 587.9m
Cash & Short-Term Investments 532.2m
Receivables 42m
Other Current Assets 13.7m
Non-Current Assets 230.4m
Long-Term Investments 62m
PP&E 168.2m
Other Non-Current Assets 263k
Current Liabilities 33.1m
Accounts Payable 4.1m
Accrued Liabilities 24.5m
Other Current Liabilities 4.5m
Non-Current Liabilities 6.6m
Other Non-Current Liabilities 6.6m

Balance Sheet
Krystal Biotech Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
2
50
104
188
268
341
162
358
Cash Equivalents
2
50
104
188
268
341
162
358
Short-Term Investments
0
0
8
6
3
97
217
174
Total Receivables
0
0
0
0
0
0
0
42
Accounts Receivables
0
0
0
0
0
0
0
42
Other Receivables
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
7
Other Current Assets
0
0
1
2
4
4
5
7
Total Current Assets
2
50
113
196
275
442
384
588
PP&E Net
0
0
3
11
34
120
170
168
PP&E Gross
0
0
3
11
34
120
170
168
Accumulated Depreciation
0
0
0
1
2
4
7
13
Long-Term Investments
0
0
0
1
0
64
5
62
Other Long-Term Assets
0
0
1
2
2
0
0
0
Total Assets
2
N/A
50
+2 177%
116
+132%
209
+80%
311
+49%
626
+102%
559
-11%
818
+47%
Liabilities
Accounts Payable
0
0
1
1
2
8
4
4
Accrued Liabilities
0
0
2
3
6
17
25
24
Short-Term Debt
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
8
0
0
4
Total Current Liabilities
0
1
3
3
16
26
29
33
Long-Term Debt
2
0
0
0
0
0
0
0
Other Liabilities
0
0
0
3
3
7
7
7
Total Liabilities
2
N/A
1
-68%
3
+383%
6
+110%
19
+208%
33
+74%
36
+11%
40
+10%
Equity
Common Stock
1
0
0
0
0
0
0
0
Retained Earnings
1
9
20
39
71
141
281
270
Additional Paid In Capital
0
59
133
242
363
735
804
1 048
Other Equity
0
0
0
0
0
0
1
1
Total Equity
0
N/A
50
+16 400%
113
+129%
203
+79%
292
+44%
594
+103%
522
-12%
779
+49%
Total Liabilities & Equity
2
N/A
50
+2 177%
116
+132%
209
+80%
311
+49%
626
+102%
559
-11%
818
+47%
Shares Outstanding
Common Shares Outstanding
9
10
14
17
20
25
26
28

See Also

Summary
KRYS intrinsic value, competitors valuation, and company profile.
DCF Valuation
KRYS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KRYS stock valuation using valuation multiples.
Wall Street Estimates
KRYS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KRYS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.